It can promote the progression of prostate diseases through multiple mechanisms, including the induction of DNA damage, activation of inflammatory signaling pathways, disruption of the balance between cell proliferation and apoptosis, and regulation of the HIF-1α-mediated hypoxia response and the NF-κB-driven inflammation-tumor signaling axis. Here, NFKB1 is linked to prostatitis.